Industry Resources | October 17, 2012
Genetics, Neurotech & Personalized Medicine: Using Emerging Science To Improve Treatment Of Cognitive Disorders
October 17, 2012
This presentation, lead by Sue McMonigle, Vice President, Marketing, Neuronetics, Inc., Nancy Grden, General Manager, Genomind, LLC , and John F. Talbot, Ph.D., Executive Vice President, OPEN MINDS was given on October 17, 2012 at the OPEN MINDS 2012 Technology & Informatics Institute in Baltimore, Maryland. The panel of experts articulated the implications of these new technologies for consumers, and how organizations of the future will deliver service. Topics included the implications of personalized medicine for service provider organizations, a review of the latest developments in genetics and neurotechnology, and . . .